HK1001853A1 - Matrix type patch preparation - Google Patents
Matrix type patch preparationInfo
- Publication number
- HK1001853A1 HK1001853A1 HK98100885A HK98100885A HK1001853A1 HK 1001853 A1 HK1001853 A1 HK 1001853A1 HK 98100885 A HK98100885 A HK 98100885A HK 98100885 A HK98100885 A HK 98100885A HK 1001853 A1 HK1001853 A1 HK 1001853A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- matrix type
- type patch
- active substance
- acid
- physiological active
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Botany (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Manufacture Of Alloys Or Alloy Compounds (AREA)
- Curing Cements, Concrete, And Artificial Stone (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Steroid Compounds (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP31911794A JP3908795B2 (ja) | 1994-11-29 | 1994-11-29 | ケトチフェン含有経皮投与製剤 |
PCT/JP1995/001073 WO1996016642A1 (fr) | 1994-11-29 | 1995-06-01 | Composition de timbre transdermique du type matriciel |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1001853A1 true HK1001853A1 (en) | 1998-07-17 |
Family
ID=18106658
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK98100885A HK1001853A1 (en) | 1994-11-29 | 1998-02-05 | Matrix type patch preparation |
Country Status (14)
Country | Link |
---|---|
US (1) | US5866157A (de) |
EP (1) | EP0788792B1 (de) |
JP (1) | JP3908795B2 (de) |
KR (1) | KR100385268B1 (de) |
CN (1) | CN1065428C (de) |
AT (1) | ATE229798T1 (de) |
AU (1) | AU708123B2 (de) |
CA (1) | CA2206303A1 (de) |
DE (1) | DE69529228T2 (de) |
DK (1) | DK0788792T3 (de) |
ES (1) | ES2184801T3 (de) |
HK (1) | HK1001853A1 (de) |
PT (1) | PT788792E (de) |
WO (1) | WO1996016642A1 (de) |
Families Citing this family (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW411277B (en) * | 1996-05-13 | 2000-11-11 | Hisamitsu Pharmaceutical Co | Percutaneous tape preparation containing fentanyl |
AU735944B2 (en) * | 1997-02-28 | 2001-07-19 | Minnesota Mining And Manufacturing Company | Transdermal device for the delivery of testosterone |
EP1007597B1 (de) * | 1997-08-29 | 2003-04-23 | Avery Dennison Corporation | Biologische flüssigkeitsabsorbierende druckempfindliche klebstoffe |
US6180133B1 (en) * | 1997-11-25 | 2001-01-30 | Watson Pharmaceuticals, Inc. | Antioxidant composition for topical/transdermal prevention and treatment of wrinkles |
JP4205778B2 (ja) * | 1998-04-17 | 2009-01-07 | 久光製薬株式会社 | 貼付製剤 |
WO2000001384A1 (fr) * | 1998-07-01 | 2000-01-13 | Lead Chemical Co., Ltd. | Preparation a base de ketotifene destinee a etre absorbee par voie percutanee |
JP3943724B2 (ja) * | 1998-07-31 | 2007-07-11 | 東光薬品工業株式会社 | フェンタニル含有経皮投与マトリックス型貼付剤 |
US6953590B1 (en) * | 1998-10-05 | 2005-10-11 | Yutoku Pharmaceutical Ind. Co., Ltd. | Tape material for transcutaneous absorption |
US6475514B1 (en) * | 1998-12-03 | 2002-11-05 | Andrew Blitzer | Athletic patch |
US7504114B1 (en) * | 1999-04-13 | 2009-03-17 | Hisamitsu Pharmaceuticals | Preparations for percutaneous absorption |
US6417227B1 (en) | 1999-04-28 | 2002-07-09 | Cg And Associates | Methods of delivery of cetyl myristoleate |
CN1361686A (zh) | 1999-07-15 | 2002-07-31 | 久光制药株式会社 | 经皮吸收制剂 |
DE60034458T2 (de) * | 1999-07-27 | 2008-01-03 | Hisamitsu Pharmaceutical Co., Inc., Tosu | Pflaster zur äusserlichen anwendung |
US20040142024A1 (en) * | 1999-07-27 | 2004-07-22 | Hisamitsu Pharmaceutical Co., Inc. | Patch formulation for external use |
JP4871469B2 (ja) * | 1999-10-15 | 2012-02-08 | ポーラ化成工業株式会社 | エレクトロポーレーション用の経皮吸収促進剤 |
CN1245961C (zh) * | 2000-03-17 | 2006-03-22 | 久光制药株式会社 | 紫外遮蔽性贴剂 |
ATE517614T1 (de) * | 2000-04-18 | 2011-08-15 | Hisamitsu Pharmaceutical Co | Pflaster enthaltend einen anti-inflammatorischen wirkstoff |
US7179483B2 (en) * | 2000-04-26 | 2007-02-20 | Watson Pharmaceuticals, Inc. | Compositions and methods for transdermal oxybutynin therapy |
WO2002038139A1 (fr) * | 2000-11-07 | 2002-05-16 | Hisamitsu Pharmaceutical Co., Inc. | Preparation pharmaceutique du type a absorption percutanee |
DE10056010A1 (de) * | 2000-11-11 | 2002-05-16 | Beiersdorf Ag | Pflaster mit hautpflegenden Substanzen |
DE10056011A1 (de) * | 2000-11-11 | 2002-05-16 | Beiersdorf Ag | Hautfreundliches Wirkstoffpflaster zur insbesondere transdermalen Verabreichung ätherischer Öle |
BR0207955A (pt) * | 2001-03-07 | 2004-02-25 | Hisamitsu Pharmaceutical Co | Agente de emplastro |
DE10121471A1 (de) * | 2001-05-02 | 2002-11-07 | Beiersdorf Ag | Oberflächendotierte wirkstoffhaltige Pflaster |
JP4489356B2 (ja) * | 2001-05-11 | 2010-06-23 | メリオン リサーチ スリー リミテッド | 浸透促進剤 |
US20040241240A1 (en) * | 2001-08-10 | 2004-12-02 | Takaaki Terahara | Percutaneous absorption preparations |
US20030124174A1 (en) * | 2001-10-25 | 2003-07-03 | Endo Pharmaceuticals, Inc | Method for treating non-neuropathic pain |
AU2003241322A1 (en) * | 2002-04-30 | 2003-11-17 | Npd Llc | Multi-phasic delivery via transmucosal absorption of antiemetic medicaments |
US20050163831A1 (en) * | 2002-08-02 | 2005-07-28 | Hisamitsu Pharmaceutical Co., Inc. | Patch for transdermal administration |
JP4792193B2 (ja) * | 2002-08-28 | 2011-10-12 | 久光製薬株式会社 | 貼付剤 |
JP4354678B2 (ja) * | 2002-08-28 | 2009-10-28 | 久光製薬株式会社 | 貼付剤 |
JP4758101B2 (ja) * | 2002-09-13 | 2011-08-24 | 久光製薬株式会社 | 貼付剤 |
JP4543274B2 (ja) * | 2002-10-01 | 2010-09-15 | 大正製薬株式会社 | 点鼻剤組成物 |
TWI296531B (en) * | 2002-10-18 | 2008-05-11 | Hisamitsu Pharmaceutical Co | Transdermal adhesive preparations for topical administration of fentanyl |
KR20120035220A (ko) * | 2003-01-22 | 2012-04-13 | 센주 세이야꾸 가부시키가이샤 | 안질환 치료용 경피 흡수형 제제, 그 사용, 및 안질환 치료약의 눈의 국소 조직으로의 이행 방법 |
EP1594483B1 (de) * | 2003-02-21 | 2006-07-19 | Schering AG | Uv-stabiles transdermales pflaster |
US8790689B2 (en) | 2003-04-30 | 2014-07-29 | Purdue Pharma L.P. | Tamper resistant transdermal dosage form |
EA009623B1 (ru) * | 2003-04-30 | 2008-02-28 | Пэдью Фарма Л.П. | Устойчивая к манипуляциям дозировочная форма для трансдермального введения |
EP1557164A4 (de) * | 2003-06-20 | 2006-03-15 | Teikoku Seiyaku Kk | Klebepflaster mit tulobuterol |
ES2449042T3 (es) * | 2003-07-31 | 2014-03-18 | Hisamitsu Pharmaceutical Co., Inc. | Parche adhesivo |
JP4468669B2 (ja) * | 2003-09-22 | 2010-05-26 | 久光製薬株式会社 | 低刺激性貼付剤 |
WO2005046600A2 (en) * | 2003-11-07 | 2005-05-26 | Nexmed Holdings, Inc. | Transdermal tulobuterol delivery |
US20050112183A1 (en) * | 2003-11-25 | 2005-05-26 | Galer Bradley S. | Compositions and methods for treating neuropathic sensory loss |
US8668925B2 (en) | 2003-12-12 | 2014-03-11 | Bayer Intellectual Property Gmbh | Transdermal delivery of hormones without the need of penetration enhancers |
CN1905866B (zh) * | 2004-01-20 | 2011-01-05 | 尼普洛外用药品株式会社 | 妥洛特罗贴剂 |
WO2005072716A1 (ja) * | 2004-01-30 | 2005-08-11 | Hisamitsu Pharmaceutical Co., Inc. | 貼付剤入り包装袋 |
US20080038328A1 (en) * | 2004-05-28 | 2008-02-14 | Naruhito Higo | Pasting Preparation |
JPWO2005117886A1 (ja) * | 2004-06-01 | 2008-04-03 | 久光製薬株式会社 | 貼付剤 |
JP4745747B2 (ja) | 2004-08-12 | 2011-08-10 | 日東電工株式会社 | フェンタニル含有貼付製剤 |
JP4824963B2 (ja) | 2004-08-12 | 2011-11-30 | 日東電工株式会社 | 貼付材及び貼付製剤 |
JP5075334B2 (ja) * | 2004-11-22 | 2012-11-21 | 久光製薬株式会社 | 薬物含有貼付剤 |
ATE413166T1 (de) | 2004-11-22 | 2008-11-15 | Hisamitsu Pharmaceutical Co | Transdermales pflaster enthaltend einen schmelzpunktsenkenden hilfsstoff |
EP1857103B1 (de) * | 2005-02-28 | 2018-10-24 | Hisamitsu Pharmaceutical Co., Inc. | Transdermal absorbierbare präparation |
US8962013B2 (en) * | 2005-05-02 | 2015-02-24 | Bayer Intellectual Property Gmbh | Multi-layered transdermal system with triazine UV absorber |
ES2388355T3 (es) | 2006-11-03 | 2012-10-11 | Durect Corporation | Sistemas de suministro transdémico que comprenden bupivacaína |
US20080152592A1 (en) * | 2006-12-21 | 2008-06-26 | Bayer Healthcare Llc | Method of therapeutic drug monitoring |
JP5275047B2 (ja) * | 2007-01-31 | 2013-08-28 | 久光製薬株式会社 | 経皮または経粘膜投与のためのアジュバントおよびこれを含む医薬製剤 |
US20100210932A1 (en) * | 2007-03-20 | 2010-08-19 | Bayer Healthcare Llc | Method of analyzing an analyte |
JP5242950B2 (ja) * | 2007-06-15 | 2013-07-24 | 日東電工株式会社 | ゲル組成物およびその用途 |
ES2661767T3 (es) * | 2008-02-27 | 2018-04-03 | Hisamitsu Pharmaceutical Co., Inc. | Parche adhesivo para la piel y producto envasado |
WO2009107476A1 (ja) | 2008-02-27 | 2009-09-03 | 久光製薬株式会社 | 貼付製剤 |
JP2012158572A (ja) * | 2011-02-02 | 2012-08-23 | Nitto Denko Corp | 貼付製剤の製造方法 |
WO2014057928A1 (ja) * | 2012-10-11 | 2014-04-17 | 久光製薬株式会社 | 貼付剤 |
US8697043B1 (en) | 2013-01-08 | 2014-04-15 | Chattem, Inc. | Odor suppression of volatile organic analgesic compounds and method of use |
US20140234394A1 (en) * | 2013-02-19 | 2014-08-21 | William A. McDonough | Benefical contact surfaces for functional objects |
JP6151935B2 (ja) * | 2013-03-11 | 2017-06-21 | 日東電工株式会社 | 経皮吸収促進用組成物および貼付製剤 |
EP3045166B1 (de) | 2013-09-11 | 2020-12-16 | MEDRx Co., Ltd. | Neuartige basiszusammensetzung für ein bandmittel |
CN109966241A (zh) * | 2019-04-16 | 2019-07-05 | 浙江大学 | 一种促渗组合物在外用制剂经皮促渗中的应用 |
CN110507638A (zh) * | 2019-10-14 | 2019-11-29 | 姜涛 | 一种膏药、贴剂专用基质 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2915887A1 (de) * | 1979-04-19 | 1980-11-06 | Wacker Chemie Gmbh | Copolymerisate auf der basis von acrylestern, vinylacetat und aethylen |
JPS56140916A (en) * | 1980-04-04 | 1981-11-04 | Sekisui Chem Co Ltd | Adhesive tape or sheet for medical treatment |
IL72684A (en) * | 1984-08-14 | 1989-02-28 | Israel State | Pharmaceutical compositions for controlled transdermal delivery of cholinergic or anticholinergic basic drugs |
JPS62181226A (ja) * | 1986-02-05 | 1987-08-08 | Ikeda Mohandou:Kk | 消炎鎮痛外用剤 |
JP2572763B2 (ja) * | 1987-04-02 | 1997-01-16 | 帝國製薬株式会社 | エトフェナマ−ト含有貼付薬 |
JPH01290630A (ja) * | 1988-05-17 | 1989-11-22 | Takeda Chem Ind Ltd | 経皮用製剤 |
JP2788754B2 (ja) * | 1989-05-12 | 1998-08-20 | 日東電工株式会社 | シート状経皮吸収デバイス |
DE69010076T2 (de) * | 1989-05-25 | 1994-12-08 | Takeda Chemical Industries Ltd | Transdermales therapeutisches Mittel. |
JP2849937B2 (ja) * | 1990-04-18 | 1999-01-27 | 日東電工株式会社 | 医療用貼付剤 |
US5225199A (en) * | 1990-04-24 | 1993-07-06 | Teijin Limited | Pharmaceutical plasters |
ATE176153T1 (de) * | 1991-08-30 | 1999-02-15 | Hisamitsu Pharmaceutical Co | Entzündungshemmendes, analgetisches pflaster |
JPH06100439A (ja) * | 1992-09-18 | 1994-04-12 | Sekisui Chem Co Ltd | 経皮吸収貼付剤 |
GB2273044B (en) * | 1992-12-02 | 1997-04-09 | Pacific Chem Co Ltd | Medicinal patches for percutaneous administration |
-
1994
- 1994-11-29 JP JP31911794A patent/JP3908795B2/ja not_active Expired - Lifetime
-
1995
- 1995-06-01 DK DK95920235T patent/DK0788792T3/da active
- 1995-06-01 DE DE69529228T patent/DE69529228T2/de not_active Expired - Lifetime
- 1995-06-01 WO PCT/JP1995/001073 patent/WO1996016642A1/ja active IP Right Grant
- 1995-06-01 AU AU25756/95A patent/AU708123B2/en not_active Ceased
- 1995-06-01 ES ES95920235T patent/ES2184801T3/es not_active Expired - Lifetime
- 1995-06-01 CA CA002206303A patent/CA2206303A1/en not_active Abandoned
- 1995-06-01 PT PT95920235T patent/PT788792E/pt unknown
- 1995-06-01 AT AT95920235T patent/ATE229798T1/de not_active IP Right Cessation
- 1995-06-01 EP EP95920235A patent/EP0788792B1/de not_active Expired - Lifetime
- 1995-06-01 CN CN95197130A patent/CN1065428C/zh not_active Expired - Fee Related
- 1995-06-01 KR KR1019970703590A patent/KR100385268B1/ko not_active IP Right Cessation
- 1995-06-01 US US08/836,975 patent/US5866157A/en not_active Expired - Lifetime
-
1998
- 1998-02-05 HK HK98100885A patent/HK1001853A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0788792A1 (de) | 1997-08-13 |
AU2575695A (en) | 1996-06-19 |
DK0788792T3 (da) | 2003-01-13 |
JPH08157365A (ja) | 1996-06-18 |
JP3908795B2 (ja) | 2007-04-25 |
CN1171736A (zh) | 1998-01-28 |
WO1996016642A1 (fr) | 1996-06-06 |
PT788792E (pt) | 2003-03-31 |
EP0788792B1 (de) | 2002-12-18 |
AU708123B2 (en) | 1999-07-29 |
EP0788792A4 (de) | 1998-05-27 |
DE69529228T2 (de) | 2003-07-17 |
US5866157A (en) | 1999-02-02 |
DE69529228D1 (de) | 2003-01-30 |
ATE229798T1 (de) | 2003-01-15 |
KR100385268B1 (ko) | 2003-08-19 |
CA2206303A1 (en) | 1996-06-06 |
CN1065428C (zh) | 2001-05-09 |
ES2184801T3 (es) | 2003-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1001853A1 (en) | Matrix type patch preparation | |
US4743588A (en) | Compositions and methods of enhancing transdermal and transmembrane penetration systemic agents | |
CA2217888A1 (en) | Triacetin as a transdermal penetration enhancer | |
DE69434963D1 (de) | Selektiv auf die leber wirkende pharmazeutisch aktive substanz | |
NO173365C (no) | Fremgangsm}te for fremstilling av et i det vesentlige ikke-sviende, vandig, antiinflammatorisk steroidpreparat egnet for intranasal administerering | |
EP0747092A3 (de) | Lösungsflüssigkeit für durch Iontophorese zugeführte Medikamente | |
EP0974350A4 (de) | Tranilast enthaltendes externum und verfahren zu dessen herstellung | |
EP0206291A3 (en) | Sprayable pharmaceutical preparation for topical application | |
IE940583L (en) | Topical antimicrobial pharmaceutical compositions | |
DK0582239T3 (da) | Farmaceutisk og/eller kosmetisk formulering | |
NO954691D0 (no) | Reduksjon av liposom-indusert ugunstige fysiologiske reaksjoner | |
ATE173932T1 (de) | Silikat-polymer enthaltende pharmazeutische zusammensetzungen | |
DK1197209T3 (da) | Perkutant absorberbare præparater | |
CA2200189A1 (en) | Scopolamine plaster | |
IL90056A (en) | Topical pharmaceutical compositions containing 4-quinoline carboxylic acid derivatives | |
EP0746294B1 (de) | Absorptionsförderer für topische pharmazeutische formulierungen | |
CA2036592A1 (en) | Therapeutic agent for diabetic gangrene | |
Hollingsbee et al. | The effect of a hydrocolloid dermatological patch (Actiderm) in potentiating the skin blanching activity of triamcinolone acetonide | |
IL78269A (en) | Dermatological therapeutical compositions containing imidazolidinylurea derivative | |
AU3202393A (en) | Cyclic amp derivative-containing ointment | |
CA2244679A1 (en) | Tranilast-containing preparation for external application and method of producing the same | |
AU4773290A (en) | Sustained release pharmaceutical composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PF | Patent in force | ||
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20070601 |